Heilongjiang, China

Yijie Cao



Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2021

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Yijie Cao: Innovator in Medicinal Chemistry

Introduction

Yijie Cao is a prominent inventor based in Heilongjiang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating neurological conditions. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Yijie Cao holds 1 patent for his invention titled "Salts and crystal forms of diaza-benzofluoranthrene compounds." This patent discloses various salts, including hydrochloride, citrate, phosphate, and sulfate salts of compound 1. The invention also details the crystal forms of these salts and their preparation methods. Furthermore, it highlights their potential use in creating medicaments for treating cerebral apoplexy or epilepsy.

Career Highlights

Cao is currently employed at Harbin Pharmaceutical Group Co., Ltd., specifically in the General Pharmaceutical Factory. His role involves research and development, where he applies his expertise in medicinal chemistry to create effective pharmaceutical products. His innovative approach has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Yijie Cao has collaborated with notable colleagues, including Qingqing Lu and Shenyi Shi. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in medicinal chemistry.

Conclusion

Yijie Cao's contributions to the field of medicinal chemistry exemplify the impact of innovation in healthcare. His patent for diaza-benzofluoranthrene compounds showcases his commitment to developing effective treatments for serious medical conditions. Through his work, he continues to advance the pharmaceutical industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…